Collagen News and Research

Latest Collagen News and Research

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).

24 Aug 2010

Wound Management Technologies' CellerateRX introduced at DFWG congress in South Africa

Wound Management Technologies, Inc. announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working Group) congress in Cape Town and has already planned exhibitions at two additional upcoming conferences. This second meeting of the DFWG congress was attended by over 120 diabetic foot specialists.

18 Aug 2010

Study on differential aspects of cardiac insufficiency due to high blood pressure amongst women and men

Doctor Elena Zubillaga studied 109 women and 120 men admitted to hospital with a cardiac insufficiency solely due to high blood pressure. More concretely, she analysed the clinical, biochemical and ecocardiographical differences between the patients, depending on their sex. She also made reference to the data provided by serum markers for the metabolism of the collagen in the heart and the systolic function or contraction of the latter, as alterations taking place in the metabolism of myocardial collagen are associated with certain clinical situations.

18 Aug 2010

Regenicin acquires worldwide exclusive license to know-how technology

Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").

18 Aug 2010

Study deems gentamicin-collagen sponge ineffective in reducing sternal wound infections

Contradicting previous study results, insertion of a sponge that contains the antibiotic gentamicin at the time of surgical closure following cardiac surgery did not reduce the rate of sternal wound infections after 3 months, compared to patients who did not receive the intervention, according to a study in the August 18 issue of JAMA.

18 Aug 2010

Medtronic to acquire Osteotech for $6.50 per share

Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.

18 Aug 2010

Ancient discovery holds key to joint tissue regeneration

Osteoarthritis is a crippling disease worldwide, with an estimated eight million sufferers in the UK alone. It has been described as like "wearing a suit of rusty armour," with unrelenting, razor-like pain.

17 Aug 2010

Pelleve Wrinkle Reduction System launched across U.S.

Pelleve, the revolutionary skin tightening system for nonablative skin rejuvenation, is now available through dermatologists, plastic surgeons, medspas and cosmetic surgery clinics across the country.

12 Aug 2010

$Study demonstrates efficacy of vertebroplasty in treatment of acute vertebral compression fractures$

Study demonstrates efficacy of vertebroplasty in treatment of acute vertebral compression fractures

Orthovita, Inc., an orthobiologics and biosurgery company, notes that the August 10, 2010 online edition of The Lancet includes the largest peer-reviewed study to date demonstrating the efficacy of vertebroplasty in the treatment of acute vertebral compression fractures compared to conservative treatment.

12 Aug 2010

Wound Management Technologies introduces CellerateRX wound care collagen product in South Africa

Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.

12 Aug 2010

Study examines cosmetic impact of surgical procedure for body dysmorphic disorder

A new study finds that while many who suffer from body dysmorphic disorder (BDD) seek cosmetic procedures, only two percent of procedures actually reduced the severity of BDD. Despite this poor long-term outcome, physicians continue to provide requested surgeries to people suffering from BDD. The study was recently published in Annals of Plastic Surgery.

12 Aug 2010

Cardium second-quarter net loss decreases to $0.7 million

Cardium Therapeutics today reported highlights and financial results for its second quarter ended June 30, 2010.

10 Aug 2010

CryoPatch SG pulmonary human cardiac patch receives FDA clearance for 5-year shelf-life extension

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.

9 Aug 2010

New soft-tissue fillers for skin tightening, volume restoration in cheek area

Now, armed with a deeper understanding of full facial contouring, dermatologists are using soft-tissue fillers to enhance and restore volume loss in the cheek area, thereby smoothing nasolabial folds (the wrinkles that form along the bottom of the nose to the corners of the mouth). In addition, newly introduced fractional radiofrequency technology to address skin laxity is showing promise by stimulating collagen contraction and reducing loose skin in the lower-face.

6 Aug 2010

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

6 Aug 2010

Study identifies options for restoring knee cartilage lubrication to prevent OA

An injury to the anterior cruciate ligament is fairly common, especially among young athletes. While it can often be corrected through surgery, the injury can lead to increased risk of developing degenerative joint diseases, including osteoarthritis. The problem is that fluid in the knee joint, which lubricates the cartilage, is impacted by the trauma of the injury and begins to deteriorate.

6 Aug 2010

Scientists develop revolutionary approach for reconstructing intricate bone tissue

Every year nearly 6.2 million bone fractures occur in the United States as a result of trauma and disease. Current standards for bone repair can lead to rapid bone fusion but with limited mechanical strength often due to the lack of cortical bone tissue which is difficult to harvest without pain and severe morbidity. Funded by the National Science Foundation, Dr. Hongjun Wang, a professor in the Department of Chemistry, Chemical Biology and Biomedical Engineering at Stevens Institute of Technology and his collaborators have developed a revolutionary "bottom-up" approach for reconstructing intricate bone tissue with the potential to form hierarchical cortical bone.

5 Aug 2010

Long-term exposure to valproate leads to bone loss: Study

Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength, they said. Their study, which offers a solution to a long-standing mystery, appears in ACS' monthly Journal of Proteome Research.

5 Aug 2010

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the second quarter ended July 2, 2010. Revenue for the period grew 3.7% to $13.6 million with the revenue from core products, IOLs and ICLs, increasing by 7%. For the first half of 2010 core product revenues increased by 11% reflecting market share gains by STAAR.

4 Aug 2010

Orthovita second-quarter operating income improves to $0.4 million

Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.

3 Aug 2010

Collagen News and Research

Latest Collagen News and Research

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

Wound Management Technologies' CellerateRX introduced at DFWG congress in South Africa

Study on differential aspects of cardiac insufficiency due to high blood pressure amongst women and men

Regenicin acquires worldwide exclusive license to know-how technology

Study deems gentamicin-collagen sponge ineffective in reducing sternal wound infections

Medtronic to acquire Osteotech for $6.50 per share

Ancient discovery holds key to joint tissue regeneration

Pelleve Wrinkle Reduction System launched across U.S.

Study demonstrates efficacy of vertebroplasty in treatment of acute vertebral compression fractures

Wound Management Technologies introduces CellerateRX wound care collagen product in South Africa

Study examines cosmetic impact of surgical procedure for body dysmorphic disorder

Cardium second-quarter net loss decreases to $0.7 million

CryoPatch SG pulmonary human cardiac patch receives FDA clearance for 5-year shelf-life extension

New soft-tissue fillers for skin tightening, volume restoration in cheek area

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

Study identifies options for restoring knee cartilage lubrication to prevent OA

Scientists develop revolutionary approach for reconstructing intricate bone tissue

Long-term exposure to valproate leads to bone loss: Study

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

Orthovita second-quarter operating income improves to $0.4 million

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Collagen News and Research

Latest Collagen News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in